Zhejiang CONBA Pharmaceutical Co.,Ltd.

SHSE:600572 Stock Report

Market Cap: CN¥11.9b

Zhejiang CONBA PharmaceuticalLtd Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Guoliang Luo

Chief executive officer

CN¥2.0m

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership0.004%
Management average tenureno data
Board average tenureless than a year

Recent management updates

Recent updates

Zhejiang CONBA PharmaceuticalLtd's (SHSE:600572) Problems Go Beyond Weak Profit

Nov 05
Zhejiang CONBA PharmaceuticalLtd's (SHSE:600572) Problems Go Beyond Weak Profit

It's A Story Of Risk Vs Reward With Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHSE:600572)

Sep 30
It's A Story Of Risk Vs Reward With Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHSE:600572)

Is Zhejiang CONBA PharmaceuticalLtd (SHSE:600572) Using Too Much Debt?

Sep 12
Is Zhejiang CONBA PharmaceuticalLtd (SHSE:600572) Using Too Much Debt?

Is Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHSE:600572) Worth CN¥4.3 Based On Its Intrinsic Value?

Aug 20
Is Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHSE:600572) Worth CN¥4.3 Based On Its Intrinsic Value?

Here's Why Zhejiang CONBA PharmaceuticalLtd (SHSE:600572) Can Manage Its Debt Responsibly

May 21
Here's Why Zhejiang CONBA PharmaceuticalLtd (SHSE:600572) Can Manage Its Debt Responsibly

CEO

Guoliang Luo (61 yo)

no data

Tenure

CN¥1,978,800

Compensation

Mr. Guoliang Luo serves as President and Director at Zhejiang CONBA Pharmaceutical Co.,Ltd.


Board Members

NamePositionTenureCompensationOwnership
Guoliang Luo
President & Directorno dataCN¥1.98m0.0040%
CN¥ 473.0k
Ming Chen
VP, CFO & Directorno dataCN¥1.29m0.00040%
CN¥ 47.4k
Jianfeng Ye
VP & Directorless than a yearno data0.0020%
CN¥ 235.9k
Jiqiang Hu
Chairman of the Board13.7yrsCN¥2.04m4.09%
CN¥ 485.2m
Shishui Yin
Supervisory Board Chairman3.3yrsno data0.00040%
CN¥ 47.4k
Zuojun Dong
Independent Directorno dataCN¥120.00kno data
En Liu
Independent Directorno dataCN¥120.00kno data
Yongjiang Wu
Independent Directorno dataCN¥120.00kno data
Yang Wang
Directorno datano datano data
Jiuqin Lu
Independent Directorno dataCN¥120.00kno data
Yi Jiang
Co-Chairman of Boardless than a yearno datano data
Qian Jiang
Directorless than a yearno datano data

0.9yrs

Average Tenure

52yo

Average Age

Experienced Board: 600572's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 14:37
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zhejiang CONBA Pharmaceutical Co.,Ltd. is covered by 12 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shuchang LiuChangjiang Securities Co. LTD.
Feifei XuChina Merchants Securities Co. Ltd.
Ling Bo TuChina Minzu Securities